gvtcx

Genetic Analyser

MHRA Buyer Organisation Published 27 Sept 2022 Contracts Finder

key details

Value£637,000
Statuscomplete
Category (CPV) 38000000 +1 more
Deadline15 Aug 2022
Contract start23 Sept 2022
Contract end23 Sept 2027
Procedureopen
SME suitableYes
OCIDocds-b5fd17-fd027745-e40c-4c6c-984c-89023fbe0ea0

Award

SupplierValueDateStatus
LIFE TECHNOLOGIES LIMITED £400,000 22 Sept 2022 active

description

The required genetic analyser will be used to undertake both Sanger Sequencing and Fragment Analysis including the batch release of vaccines, as part of a wider sequencing core function. The system will need to be used under the Quality control system. Actual consumable and operational spend will depend on actual work flows and demand.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
11 Jul 2022 Tender (tender) · 852e5461-4c01-4f72-b783-e0eebb77762f-553670
27 Sept 2022 Award (award) · 6c211373-6a3d-4c37-a2b3-19d7449aee17-575040

more from MHRA Buyer Organisation

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.